FDA Inspection
Delta Pharma, Inc.Delta Pharma, Inc. – FDA Inspection, Apr 12, 2024
Record Details
This FDA Inspection record concerns Delta Pharma, Inc., with an inspection on April 12, 2024, issued by the New Orleans District Office, covering human drugs.
View Company Profile
ID · 3856282d-e9b3-4734-bb19-f1f6b2ce916c
Inspection Facts
- Inspection number
- 1235500
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.110(a)Written in-process control procedures
- 21 CFR 211.80(a)Written Procedures Not Followed
- 21 CFR 211.84(b)Representative Samples
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Delta Pharma, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2025 | Not classified | New Orleans District Office | Drug Quality Assurance |
| June 2, 2023 | VAI | New Orleans District Office | |
| May 20, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 23, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 24, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Delta Pharma, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.